Aikaterini Markopoulou
Neurology · Glenview, ILNPI 1568758696
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 66.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $1,194 and has fallen 69.3% since, to $366 in 2025.
Across 39 payments — averaging $88.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$1K
- Illumina, Inc.$47
- GE HealthCare$24
Across 13 payments — averaging $2919.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sunovion Pharmaceuticals Inc.$38K
What the payments were for
- Consulting fees$42012%
- Travel & lodging$1,44642%
- Food & beverage$1,59046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 32 | $2,307 |
| Boston Scientific | 5 | $1,077 |
| Illumina, Inc. | 1 | $47 |
| GE HealthCare | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERCISE$833
- ACTIVA$420
- PERCEPT PC BRAINSENSE$357
- GENERAL DBS$234
- ACTIVA PC$134
How this compares
$3,456 in reported general payments places this provider in the 70th percentile of 790 neurology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 20 | $171,825 |
| RytaryCarbidopa/Levodopa | 181 | $167,311 |
| NuplazidPimavanserin Tartrate | 16 | $96,938 |
| Droxidopa | 79 | $56,267 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 761 | $28,534 |
| MyrbetriqMirabegron | 15 | $14,168 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 298 | $12,423 |
| Pramipexole ErPramipexole Di-Hcl | 15 | $6,503 |
| RivastigmineRivastigmine Tartrate | 77 | $6,186 |
| Entacapone | 21 | $4,640 |
| Rivastigmine | 12 | $4,241 |
| Ropinirole ErRopinirole Hcl | 27 | $3,793 |
| Primidone | 122 | $3,605 |
| AmantadineAmantadine Hcl | 97 | $3,433 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 21 | $3,377 |
Paid to pharmacies, not to this prescriber.
Other neurology in Glenview
- Trupti GokaniGlenview$126K
- Augusto MiravalleChicago$1.4M
- Lori GuytonHerrin$1.1M
- Daniel WynnNorthbrook$812K
- Arthur ItkinPalos Heights$808K
- Andrew GordonLake Barrington$765K
- Martha McGrawWinfield$625K
- Reuben ValenzuelaPeoria$590K
- Adil JavedChicago$584K
- Tyler KaplanMaywood$549K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.